CareCloud (NASDAQ: CCLD) executives emphasized accelerating profitability, stronger cash generation, and a broadened product footprint during the company's fourth-quarter and full-year 2025 earnings call, highlighting strategic acquisitions and what management described as early traction for its newly launched AI offerings. 2025 results: revenue growth, first full year of positive GAAP EPS since IPO CEO Stephen Snyder
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Clover Health Investments and CareCloud are expected to gain from the GenAI wave.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Stephen A. Snyder CEO | XMUN Exchange | US14167R1005 ISIN |
| US Country | 3,650 Employees | - Last Dividend | - Last Split | - IPO Date |
CareCloud, Inc. is a prominent healthcare information technology (IT) company that offers an extensive suite of cloud-based solutions and related business services primarily to healthcare providers and hospitals within the United States. Initially established in 1999 and headquartered in Somerset, New Jersey, the company underwent a name change from MTBC, Inc. to CareCloud, Inc. in March 2021. CareCloud operates through two main segments: Healthcare IT and Medical Practice Management, catering to a diverse clientele including physicians, nurses, nurse practitioners, physician assistants, and other clinicians.